Review decisions

Showing 190 results of 291 total
Summary Safety Review - Enlite Glucose Sensor- Assessing the Potential Risk of Improper Glucose Management
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00124
Issued / Original Publication Date: 2016-11-14
Summary Safety Review - Zelboraf (vemurafenib) - Assessing the Potential Risk of Bone Marrow Side Effects (Bone Marrow Toxicity or Suppression)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00139
Issued / Original Publication Date: 2016-11-14
Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Potential Risk of Bone-Related Side Effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00132
Issued / Original Publication Date: 2016-11-14
Summary Safety Review - Loratadine - Abnormal heart rhythm (QT interval prolongation)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00129
Issued / Original Publication Date: 2016-11-09
Summary Safety Review - Rivastigmine (Exelon and generics) - Assessing the Potential Increased Risk of Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00131
Issued / Original Publication Date: 2016-11-09
Summary Safety Review - Interferon beta products - Assessing the Potential Risk of Pulmonary Arterial Hypertension
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00127
Issued / Original Publication Date: 2016-11-02
Updated Date: 2016-11-30
Summary Safety Review - Cervarix (Human Papillomavirus vaccine Types 16 and 18 [Recombinant, AS04 adjuvanted]) - Assessing the Potential Risk of a Condition in which the body's defense system damages nerves (Guillain-Barré Syndrome)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00122
Issued / Original Publication Date: 2016-10-27
Summary Safety Review - Havrix (hepatitis A vaccine, inactivated) - Assessing the Potential Risk of Decreased Amounts of Blood Platelets (thrombocytopenia)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00125
Issued / Original Publication Date: 2016-10-27
Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA) - Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00140
Issued / Original Publication Date: 2016-10-25
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00128
Issued / Original Publication Date: 2016-10-24

Displaying 181 - 190 of 291 | Page 19 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: